Identification and validation of molecular subtypes and prognostic models in patients with kidney cancer based on

Jiaao Sun1, Shiyan Song1, Qiancheng Ma1

  • 1First Affiliated Hospital of Dalian Medical University, Dalian, China.

BMC Cancer
|March 29, 2025
PubMed
Abstract

Insights

This study reveals the role of B cells in kidney cancer, identifying key genes to create a prognostic model for predicting patient survival and guiding personalized treatment strategies.

Area of Science:

  • Immunology
  • Oncology
  • Bioinformatics

Background:

  • B cells have complex roles in cancer, influencing both tumor growth and immune response.
  • The specific mechanisms of B cells in kidney cancer remain unclear.

Purpose of the Study:

  • To elucidate the role of B cells in kidney cancer.
  • To identify B cell-related genes and molecular subtypes.
  • To develop a prognostic model for kidney cancer survival prediction.

Main Methods:

  • Analysis of kidney cancer data from GEO and TCGA databases.
  • Single-cell landscape mapping within kidney cancer tissue.
  • Identification of B cell-related genes and molecular subtypes.
  • Construction and validation of a 6-gene prognostic model using imaging omics.

Main Results:

  • Identified 25 B-cell-related genes and associated molecular subtypes of kidney cancer.
  • Developed a 6-gene prognostic model with validated predictive performance for renal cancer survival.
  • Characterized the microenvironment of identified subtypes and analyzed protein structures of model genes.

Conclusions:

  • This study provides the first comprehensive exploration of B cell involvement in kidney cancer.
  • A novel bio-predictive model based on B cell-related genes offers guidance for personalized kidney cancer treatment.